Literature DB >> 27050062

Frailty and Pre-Frailty in a Contemporary Cohort of HIV-Infected Adults.

N F Önen1, P Patel, J Baker, L Conley, J T Brooks, T Bush, K Henry, J Hammer, E M Kojic, E T Overton.   

Abstract

OBJECTIVES: To determine the prevalence of pre-frailty among HIV-infected persons and associations with pre-frailty and frailty in this population. DESIGN, SETTING AND PARTICIPANTS: From a contemporary, prospective observational cohort of HIV-infected persons (SUN Study), we determined, using a cross-sectional analytic study design, the proportions of non-frail, pre-frail, and frail persons by the respective presence of 0, 1-2, and ≥ 3 of 5 established frailty criteria: unintentional weight loss, exhaustion, physical-inactivity, weak-grip and slow-walk. We evaluated associations with pre-frailty/frailty using multivariate analysis.
RESULTS: Of 322 participants assessed (79% men, 58% white non-Hispanic, median age 47 years, 95% on combination antiretroviral therapy [cART], median CD4 + cell count 641 cells/mm3 and 93% HIV RNA < 400 copies/mL), 57% were non-frail, 38% pre-frail, and 5% frail. Age increased from non-frailty through frailty. Notably, however, half of pre-frail and frail participants were < 50 years, and of those, 42% and 100%, respectively, were long-term unemployed (versus 16% of non-frail counterparts). In multivariate analysis, pre-frail/frail participants were more likely to have Hepatitis C seropositivity (adjusted odds ratio [aOR] 3.24, 95% CI: 1.35-7.78), a history of AIDS-defining-illness (aOR 3.51, 95% CI: 1.82-6.76), greater depressive symptoms (aOR 1.16, 95% CI:1.09-1.23), higher D-dimer levels (aOR 2.94, 95% CI:1.10-7.87), and were less likely to be white non-Hispanic (aOR 0.35, 95% CI: 0.20-0.61).
CONCLUSIONS: Pre-frailty and frailty are prevalent in the cART era and are associated with unemployment even among persons < 50 years. Pre-frailty appears to be an intermediate state in the spectrum from non-frailty through frailty and our characterization of pre-frailty/frailty suggests complex multifactorial associations.

Entities:  

Year:  2014        PMID: 27050062      PMCID: PMC5476958          DOI: 10.14283/jfa.2014.18

Source DB:  PubMed          Journal:  J Frailty Aging        ISSN: 2260-1341


  30 in total

Review 1.  HIV infection, inflammation, immunosenescence, and aging.

Authors:  Steven G Deeks
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

2.  Frailty in older Mexican-American and European-American adults: is there an ethnic disparity?

Authors:  Sara E Espinoza; Helen P Hazuda
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

3.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

4.  Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans.

Authors:  Diana Nurutdinova; Timothy Chrusciel; Angelique Zeringue; Jeffrey F Scherrer; Ziyad Al-Aly; Jay R McDonald; Edgar T Overton
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

5.  The association of race with frailty: the cardiovascular health study.

Authors:  Calvin Hirsch; Melissa L Anderson; Anne Newman; Willem Kop; Sharon Jackson; John Gottdiener; Russell Tracy; Linda P Fried
Journal:  Ann Epidemiol       Date:  2006-01-04       Impact factor: 3.797

6.  A novel aging phenotype of slow gait, impaired executive function, and depressive symptoms: relationship to blood pressure and other cardiovascular risks.

Authors:  Ihab Hajjar; Frances Yang; Farzaneh Sorond; Richard N Jones; William Milberg; L Adrienne Cupples; Lewis A Lipsitz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-06-17       Impact factor: 6.053

7.  Frailty among community-dwelling elderly people in France: the three-city study.

Authors:  José Alberto Avila-Funes; Catherine Helmer; Hélène Amieva; Pascale Barberger-Gateau; Mélanie Le Goff; Karen Ritchie; Florence Portet; Isabelle Carrière; Béatrice Tavernier; Luis Miguel Gutiérrez-Robledo; Jean-François Dartigues
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-10       Impact factor: 6.053

Review 8.  Neurologic complications of hepatitis C.

Authors:  Jayant N Acharya; Vitor H Pacheco
Journal:  Neurologist       Date:  2008-05       Impact factor: 1.398

Review 9.  HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications.

Authors:  M Andreoni; A Giacometti; I Maida; P Meraviglia; D Ripamonti; L Sarmati
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-10       Impact factor: 3.507

10.  The high comorbidity burden of the hepatitis C virus infected population in the United States.

Authors:  Karly S Louie; Samantha St Laurent; Ulla M Forssen; Linda M Mundy; Jeanne M Pimenta
Journal:  BMC Infect Dis       Date:  2012-04-11       Impact factor: 3.090

View more
  16 in total

1.  Physical Function and Frailty in HIV.

Authors:  Kristine M Erlandson
Journal:  Top Antivir Med       Date:  2020 Dec-Jan

2.  The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and Aging.

Authors:  Stephanie Shiau; Alexis A Bender; Jane A O'Halloran; Erin Sundermann; Juhi Aggarwal; Keri N Althoff; Jason V Baker; Steven Deeks; Linda P Fried; Stephen Karpiak; Maile Y Karris; Thomas D Marcotte; Jean B Nachega; Joseph B Margolick; Kristine M Erlandson; David J Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2020-09-23       Impact factor: 2.205

3.  Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living With Human Immunodeficiency Virus.

Authors:  Kristine M Erlandson; Jeremiah Perez; Mona Abdo; Kevin Robertson; Ronald J Ellis; Susan L Koletar; Robert Kalayjian; Babafemi Taiwo; Frank J Palella; Katherine Tassiopoulos
Journal:  Clin Infect Dis       Date:  2019-01-01       Impact factor: 9.079

Review 4.  HIV and Aging: Reconsidering the Approach to Management of Comorbidities.

Authors:  Kristine M Erlandson; Maile Y Karris
Journal:  Infect Dis Clin North Am       Date:  2019-09       Impact factor: 5.982

Review 5.  Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs.

Authors:  Damani A Piggott; Kristine M Erlandson; Kevin E Yarasheski
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

Review 6.  Inflammation Strikes Again: Frailty and HIV.

Authors:  Stephanie M Fukui; Damani A Piggott; Kristine M Erlandson
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

7.  HIV serostatus, inflammatory biomarkers and the frailty phenotype among older people in rural KwaZulu-Natal, South Africa.

Authors:  Anita Edwards; Mark J Siedner; Stephen Nash; Melissa Neuman; Sivapragashini Danaviah; Theresa Smit; Dickman Gareta; Paul Kowal; Janet Seeley
Journal:  Afr J AIDS Res       Date:  2020-09-05       Impact factor: 1.300

8.  Brief Report: Frailty and HIV Disease Severity Synergistically Increase Risk of HIV-Associated Neurocognitive Disorders.

Authors:  Ni Sun-Suslow; Emily W Paolillo; Erin E Morgan; Scott Letendre; Jennifer Iudicello; David J Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2020-08-15       Impact factor: 3.731

9.  Multimorbidity networks associated with frailty among middle-aged and older people with HIV.

Authors:  David R Lorenz; Shibani S Mukerji; Vikas Misra; Hajime Uno; Benjamin B Gelman; David J Moore; Elyse J Singer; Susan Morgello; Dana Gabuzda
Journal:  AIDS       Date:  2021-12-01       Impact factor: 4.177

10.  Low Quality of Life, Falls, and Pre-Frailty are Associated with Depressive Symptoms in Virologically Suppressed PLWHIV in Salvador, Brazil.

Authors:  Rafael Antonius Araujo; Sávio Amaral; Arthur Tolentino; Diana Zeballos; Iris Montaño; Lucca S Souza; Liliane Lins-Kusterer; Carlos Brites
Journal:  AIDS Behav       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.